These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD. Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446 [Abstract] [Full Text] [Related]
10. In vitro activity of daptomycin against Gram-positive cocci: the first multicentre study in Greece. Malli E, Spiliopoulou I, Kolonitsiou F, Klapsa D, Giannitsioti E, Pantelidi K, Pratti A, Panopoulou M, Grapsa S, Alepopoulou E, Neonakis I, Frantzidou F, Alexiou-Daniel S, Bakola D, Koutsia-Carouzou C, Malamou-Lada H, Zerva L, Vlahaki E, Kartali-Ktenidou S, Anastassiou ED, Petinaki E. Int J Antimicrob Agents; 2008 Dec; 32(6):525-8. PubMed ID: 18774268 [Abstract] [Full Text] [Related]
12. Activity of daptomycin and selected antimicrobial agents tested against Staphylococcus aureus from patients with bloodstream infections hospitalized in European medical centers. Sader HS, Watters AA, Fritsche TR, Jones RN. J Chemother; 2008 Feb; 20(1):28-32. PubMed ID: 18343740 [Abstract] [Full Text] [Related]
19. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan. Chen YH, Liu CY, Lu JJ, King CH, Hsueh PR. J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635 [Abstract] [Full Text] [Related]